Innoviva
INVA
#5384
Rank
NZ$2.73 B
Marketcap
NZ$37.08
Share price
1.41%
Change (1 day)
14.10%
Change (1 year)

Earnings for Innoviva (INVA)

Earnings in 2026 (TTM): NZ$1.03 Billion

According to Innoviva's latest financial reports the company's current earnings are NZ$0.42 Billion. In 2025 the company made an earning of NZ$0.56 Billion, an increase over its 2024 earnings that were of NZ$64.24 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innoviva from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$1.03 B83.77%
2025 NZ$0.56 B774.24%
2024 NZ$64.24 M-80.74%
2023 NZ$0.33 B-32.36%
2022 NZ$0.49 B-35.56%
2021 NZ$0.76 B25.7%
2020 NZ$0.60 B52.11%
2019 NZ$0.40 B10.77%
2018 NZ$0.36 B56.59%
2017 NZ$0.23 B125.53%
2016 NZ$0.10 B-417.36%
2015 -NZ$32.24 Million-74.49%
2014 -NZ$0.13 Billion-25.19%
2013 -NZ$0.17 Billion430.06%
2012 -NZ$31.87 Million-83.92%
2011 -NZ$0.2 Billion39.82%
2010 -NZ$0.15 Billion2.84%
2009 -NZ$0.14 Billion-8.62%
2008 -NZ$0.16 Billion-47.92%
2007 -NZ$0.29 Billion-5.92%
2006 -NZ$0.31 Billion19.8%
2005 -NZ$0.26 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.4 Billion-138.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$31.2 Million-103.03%๐Ÿ‡บ๐Ÿ‡ธ USA